GeneQuine Biotherapeutics closes Seed Financing [ 12 Nov 2012 ]
The Hamburg, Germany-based biotech startup GeneQuine Biotherapeutics today announced the completion of a seven-figure seed financing round. Investors are the German seed funds High-Tech Gründerfonds, Bonn and Innovationsstarter Fonds Hamburg. Funding will be used to perform proof-of-concept studies with the lead product - a gene therapy drug for the treatment of osteoarthritis in horses.
GeneQuine starts operations in Hamburg, Germany [ 01 Oct 2012 ]
GeneQuine Biotherapeutics, a privately-held biotech startup company, has started operations in October 2012 in Hamburg, Germany.
GeneQuine is "Best of Biotech" [ 10 May 2012 ]
GeneQuine's business case selected as one of the 3 most innovative business ideas at the international business plan competition "Best of Biotech".